Dermata Therapeutics (DRMA) Stock Chart & Stock Price History → Look Who Fired the World’s Richest Man (From Banyan Hill Publishing) (Ad) Free DRMA Stock Alerts $0.34 -0.04 (-10.53%) (As of 12:46 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Dermata Therapeutics Stock Price Performance5 Day Performance+5.07%1 Month Performance-17.35%3 Month Performance-23.20%6 Month Performance-47.10%Year-To-Date Performance-44.26%1 Year Performance-86.97% Receive DRMA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressBiden FINISHED On June 13th?Thanks to Biden’s disgraceful leadership we now have sky-high inflation… unchecked immigration… rampant crime… and a “woke mob” hell bent on destroying the America you and I know and love. Biden’s days are numbered.Click here now to see his shocking evidence. DRMA Stock Chart for Tuesday, May, 14, 2024 DRMA Chart by TradingView Dermata Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$0.36$0.38+5.94%$0.39$0.34119,664 shs$2.53 million05/10/2024$0.32$0.36+10.85%$0.41$0.33196,229 shs$2.39 million05/09/2024$0.33$0.32-0.92%$0.33$0.3227,902 shs$2.16 million05/08/2024$0.33$0.33-1.33%$0.34$0.3157,718 shs$2.18 million05/07/2024$0.34$0.33-2.82%$0.34$0.3346,710 shs$2.20 million05/06/2024$0.34$0.34+1.37%$0.36$0.3413,958 shs$2.27 million Get the Latest News and Ratings for DRMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$0.34$0.34-1.21%$0.36$0.3320,489 shs$2.24 million05/02/2024$0.33$0.34+2.29%$0.35$0.3331,197 shs$2.27 million05/01/2024$0.33$0.33+1.65%$0.34$0.337,200 shs$2.21 million04/30/2024$0.32$0.33+1.55%$0.35$0.3376,588 shs$2.18 million04/29/2024$0.34$0.32-6.01%$0.34$0.3275,873 shs$2.15 million04/26/2024$0.34$0.34+0.76%$0.36$0.3316,672 shs$2.28 million04/25/2024$0.36$0.34-4.68%$0.34$0.339,619 shs$2.27 million04/24/2024$0.34$0.36+5.03%$0.36$0.3317,359 shs$2.38 million04/23/2024$0.34$0.34+0.32%$0.36$0.3219,498 shs$2.26 million04/22/2024$0.32$0.34+5.45%$0.35$0.3237,777 shs$2.26 million04/19/2024$0.34$0.33-2.42%$0.35$0.3228,516 shs$2.20 million04/18/2024$0.29$0.34+14.68%$0.36$0.29277,468 shs$2.25 million04/17/2024$0.28$0.29+7.24%$0.30$0.26129,187 shs$1.96 million04/16/2024$0.30$0.28-8.39%$0.30$0.232.15 million shs$1.83 million04/15/2024$0.41$0.30-27.03%$0.41$0.30285,810 shs$2.00 million04/12/2024$0.40$0.41+2.84%$0.42$0.3952,061 shs$2.74 million04/11/2024$0.42$0.40-4.58%$0.42$0.3957,096 shs$2.66 million04/10/2024$0.41$0.42+1.70%$0.42$0.4018,892 shs$2.79 million04/09/2024$0.42$0.41-2.99%$0.42$0.4021,798 shs$2.75 million04/08/2024$0.42$0.42+2.37%$0.44$0.41138,573 shs$2.83 million04/05/2024$0.41$0.42+0.29%$0.44$0.4154,922 shs$2.77 million04/04/2024$0.40$0.41+2.70%$0.44$0.3993,612 shs$2.76 million04/03/2024$0.41$0.40-2.77%$0.42$0.3959,270 shs$2.68 million04/02/2024$0.42$0.41-0.60%$0.42$0.4039,126 shs$2.76 million04/01/2024$0.41$0.42+1.51%$0.42$0.4065,478 shs$2.78 million03/29/2024$0.40$0.41+2.19%$0.42$0.4041,545 shs$1.45 million03/28/2024$0.40$0.40+0.50%$0.42$0.4037,045 shs$1.42 million03/27/2024$0.40$0.40-0.98%$0.42$0.38131,992 shs$1.42 million03/26/2024$0.42$0.40-2.71%$0.42$0.4050,915 shs$1.43 million03/25/2024$0.42$0.42$0.42$0.3973,769 shs$1.47 million03/22/2024$0.40$0.42+5.03%$0.44$0.39144,378 shs$1.47 million03/21/2024$0.40$0.40-1.18%$0.44$0.38163,204 shs$1.40 million03/20/2024$0.38$0.40+4.60%$0.41$0.37117,566 shs$1.42 million03/19/2024$0.38$0.38+1.14%$0.40$0.37174,213 shs$1.35 millionLook Who Fired the World’s Richest Man (Ad)This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here.03/18/2024$0.40$0.38-4.99%$0.40$0.37143,103 shs$1.34 million03/15/2024$0.40$0.40-0.87%$0.41$0.37135,831 shs$1.41 million03/14/2024$0.41$0.40-1.06%$0.42$0.3961,306 shs$1.42 million03/13/2024$0.43$0.41-6.65%$0.43$0.4049,921 shs$1.44 million03/12/2024$0.42$0.43+4.75%$0.44$0.4163,487 shs$1.54 million03/11/2024$0.42$0.42-0.93%$0.44$0.4141,103 shs$1.47 million03/08/2024$0.42$0.43+2.10%$0.44$0.4170,097 shs$1.51 million03/07/2024$0.43$0.42-2.29%$0.45$0.4096,307 shs$1.48 million03/06/2024$0.43$0.43-0.65%$0.45$0.4229,396 shs$1.52 million03/05/2024$0.44$0.43-2.97%$0.46$0.4328,844 shs$1.53 million03/04/2024$0.45$0.44-2.14%$0.45$0.4274,485 shs$1.57 million03/01/2024$0.46$0.45-1.07%$0.46$0.4519,026 shs$1.61 million02/29/2024$0.46$0.46+0.02%$0.46$0.4467,153 shs$1.62 million02/28/2024$0.46$0.46-0.26%$0.48$0.4467,758 shs$1.63 million02/27/2024$0.47$0.46-1.37%$0.48$0.45124,587 shs$1.63 million02/26/2024$0.47$0.47-0.74%$0.51$0.43249,578 shs$1.65 million02/23/2024$0.43$0.47+10.11%$0.47$0.40273,055 shs$1.66 million02/22/2024$0.43$0.43-0.96%$0.46$0.4094,130 shs$1.51 million02/21/2024$0.44$0.43-2.62%$0.45$0.4354,206 shs$1.53 million02/20/2024$0.46$0.44-3.78%$0.46$0.4449,919 shs$1.57 million02/19/2024$0.46$0.46$0.49$0.4485,500 shs$1.63 million02/16/2024$0.47$0.46-1.08%$0.49$0.4484,489 shs$1.63 million02/15/2024$0.44$0.47+5.04%$0.49$0.44112,216 shs$1.65 million02/14/2024$0.44$0.44+0.61%$0.44$0.4343,573 shs$1.57 million02/13/2024$0.43$0.44+2.09%$0.45$0.4377,014 shs$1.56 million Related Companies: SLRX Stock Chart CNSP Stock Chart CWBR Stock Chart SXTP Stock Chart SNOA Stock Chart GLMD Stock Chart BPTH Stock Chart NTBL Stock Chart CMND Stock Chart ATXI Stock Chart Receive DRMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DRMA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dermata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.